This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Company News For Feb 26, 2019
by Zacks Equity Research
Companies In The News Are: DHR,GE,ONCE,CMTA,CRI
Danaher (DHR) Catches Eye: Stock Jumps 8.5%
by Zacks Equity Research
Danaher (DHR) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Pre-Markets Up, GE Sells Off Biopharma Biz
by Mark Vickery
With President Trump again delaying the 25% tariff rate and GE raising over $21 billion to pay down debt, futures are in the green this morning.
Positive Development on Trade War Front
by Zacks Equity Research
Positive Development on Trade War Front
Pre-Markets Up, GE Sells Off Biopharma Biz
by Mark Vickery
With President Trump again delaying the 25% tariff rate and GE raising over $21 billion to pay down debt, futures are in the green this morning.
The Zacks Analyst Blog Highlights: ExxonMobil, Merck, Danaher, Novartis and Expedia
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ExxonMobil, Merck, Danaher, Novartis and Expedia
Top Research Reports for ExxonMobil, Merck & Danaher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including ExxonMobil (XOM), Merck (MRK) and Danaher (DHR).
CSL or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CSL vs. DHR: Which Stock Is the Better Value Option?
Danaher (DHR) Q4 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Danaher's (DHR) Q4 earnings jump year over year on the back of solid performance across all its segments.
Danaher (DHR) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 0.79% and 0.80%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
MMM, DHR Q4 Earnings on Jan 29: Here are the Key Predictions
by Zacks Equity Research
Conglomerates sector's earnings are expected to decline year over year in Q4. Read to know how 3M Company (MMM) and Danaher (DHR) are likely to fare.
Can Danaher (DHR) Maintain its Beat Streak in Q4 Earnings?
by Zacks Equity Research
Strength in Life Sciences business, accretive acquisitions and a solid product portfolio are conducive to Danaher's (DHR) likely encouraging Q4 results. However, high cost of sales remains a drag.
CSL or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CSL vs. DHR: Which Stock Is the Better Value Option?
ITT or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ITT vs. DHR: Which Stock Is the Better Value Option?
ITT vs. DHR: Which Stock Is the Better Value Option?
by Zacks Equity Research
ITT vs. DHR: Which Stock Is the Better Value Option?
Danaher (DHR) Displays Bright Prospects, Headwinds Remain
by Zacks Equity Research
Sturdier demand for innovative products, along with effective implementation of Danaher Business System to boost Danaher's (DHR) revenues despite certain headwinds.
Why Is Danaher (DHR) Up 1.9% Since Last Earnings Report?
by Zacks Equity Research
Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
What's in the Offing for Macquarie (MIC) in Q3 Earnings?
by Zacks Equity Research
Strong prospects of Macquarie's (MIC) Atlantic Aviation, Contracted Power and MIC Hawaii segments are expected to be conducive to its third-quarter results.
The Zacks Analyst Blog Highlights: Oracle, Netflix, Danaher, State Street and Rogers Communications
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Oracle, Netflix, Danaher, State Street and Rogers Communications
Top Research Reports for Oracle, Netflix & Danaher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Oracle (ORCL), Netflix (NFLX) and Danaher (DHR).
Danaher (DHR) Tops Earnings Estimates in Q3, Raises '18 View
by Zacks Equity Research
Danaher's (DHR) Q3 results gain from synergies from acquired assets and core sales growth. The company raises earnings projection for 2018.
Danaher (DHR) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 2.80% and 0.88%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Honeywell (HON) to Post Q3 Earnings: Another Beat in Store?
by Zacks Equity Research
Honeywell (HON) is likely to beat Q3 earnings estimate on the back of strong end-market sales, volume leverage, ongoing investments and lower taxes.
Danaher (DHR) to Report Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Danaher's (DHR) third-quarter 2018 results to gain from effective implementation of Danaher Business System, innovation of products and focus on improving shareholder return.
Is a Surprise Coming for Danaher (DHR) This Earnings Season?
by Zacks Equity Research
Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.